MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET              MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation IRVINE, CA, and HERSTAL, BELGIUM – November 6, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: […]

Nouveau montant du capital et nouveau nombre d’actions de Mdxhealth

 COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE  20 octobre 2023, 16:00 EDT / 22:00 CET  Nouveau montant du capital et nouveau nombre d’actions de Mdxhealth  IRVINE, CA, et HERSTAL, BELGIQUE – 20 octobre 2023 – MDxHealth SA (NASDAQ/Euronext : MDXH) (“mdxhealth” ou la “Société“), une société spécialisée dans le diagnostic de précision à un stade commercial, annonce […]

Mdxhealth’s New Share Capital Amount and New Number of Shares

           NEWS RELEASE – REGULATED INFORMATION October 20, 2023, 4:00 PM EDT / 22:00 CET Mdxhealth’s New Share Capital Amount and New Number of Shares IRVINE, CA, and HERSTAL, BELGIUM – October 20, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today a announces, in accordance with Article […]

MDxHealth Reports Preliminary Q3-2023 Revenues

NEWS RELEASE – INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET             MDxHealth Reports Preliminary Q3-2023 Revenues IRVINE, CA, and HERSTAL, BELGIUM – October 9, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today reported preliminary third quarter 2023 revenues, units, and cash position. For the third quarter […]

MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting

NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONOCTOBER 2, 2023, 4:00pm ET / 22:00 CET MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting IRVINE, CA, and HERSTAL, BELGIUM – October 2, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: MDXH) (the “Company” or “mdxhealth”), a commercial-stage precision diagnostics […]

Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer

NEWS RELEASE September 26, 2023, 5:00PM EDT / 23:00 CET             Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer IRVINE, CA, and HERSTAL, BELGIUM – September 26, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a leading commercial-stage precision […]

MDxHealth communique ses résultats financiers T2 et S1 2023

COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES 23 AOÛT 2023, 16 h 00 EDT, 22 h 00 CET MDxHealth communique ses résultats financiers T2 et S1 2023   Les revenus du T2 ont augmenté de 143 % par rapport à l’année dernière pour atteindre 16,7 millions de dollars ; si l’on exclut le GPS, les revenus ont augmenté de 29 % La marge brute du T2 a […]

MDxHealth Reports Q2 and Half Year 2023 Results

NEWS RELEASE – REGULATED INFORMATION23 AUGUST 2023, 4:00PM EDT / 22:00 CET             MDxHealth Reports Q2 and Half Year 2023 Results Year-over-year Q2 revenues increase by 143% to $16.7 million; excluding GPS, revenues up 29% Q2 gross margin expanded to 59.7% up from 42.4% in the prior year period Amended GPS purchase agreement with […]